Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet

American Journal of Transplantation

Volumn 6, Issue 10, 2006, Pages 2391-2395

  Leca, N ^b   Laftavi, M ^a   Gundroo, A ^a   Kohli, R ^a   Min, I ^a   Karam, J ^a   Sridhar, N ^a   Blessios, G ^a   Venuto, R ^a   Pankewycz, O ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Hypercalcemia; Hyperparathyroidism; Kidney transplantation; Metabolic complications

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CINACALCET; PARATHYROID HORMONE;

ABSENCE OF SIDE EFFECTS; ARTICLE; BONE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ALKALINE PHOSPHATASE; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; KIDNEY TRANSPLANTATION; NAPHTHALENES; PARATHYROID HORMONE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 33748478391     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01475.x     Document Type: Article

References (29)

1. Sprague SM, Josephson MA. Bone disease after kidney transplantation. Sem Nephrol 2004; 24: 82-90.
2. Ramsey-Goldman R, Dunn JE, Dunlop DD et al. Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 1999; 14: 456-463.
3. O'Shaughnessy EA, Dahl DC, Smith CL, Kasiske BL. Risk factors for fractures in kidney transplantation. Transplant 2002; 74: 362-366.
4. Sprague SM.Mechanism of transplant-associated bone loss. Ped Nephrol 2000; 14: 650-653.
5. Rubello D, Giannini S, D'Angelo A et al. Secondary hyperparathyroidism is associated with vitamin D receptor polymorphism and bone density after renal transplantation. Biomed Pharmacother 2005; 59: 402-407.
6. Brandenburg VM, Westenfeld R, Ketteler M. The fate of bone after renal transplantation. J Nephrol 2004; 17: 190-204.
7. Carlini RG, Rojas E, Weisinger JR et al. Bone disease in patients with long-term renal transplantation and normal renal function. Amer J Kid Dis 2000; 36: 160-166.
8. Dumoulin G, Hory B, Nguyen NU et al. No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients. Amer J Kid Dis 1997; 29: 746-753.
9. Torres A, Rodriguez AP, Concepcion MT et al. Parathyroid function in long-term renal transplant patients: Importance of pretransplant PTH concentrations. Nephrol Dial Transplant 1998; 13: 94-97.
10. Cayco AV, Wysolmerski J, Simpson C et al. Posttransplant bone disease: Evidence for a high bone resorption state. Transplant 2000; 70: 1722-1728.
11. Torres A, Lorenzo V, Salido E. Calcium metabolism and skeletal problems after transplantation. J Amer Soc Nephrol 2002; 13: 551-558.
12. Messa P, Sindici C, Cannella G et al. Persistent secondary hyperparathyroidism after renal transplantation. Kid Intern 1998; 54: 1704-1713.
13. Lewin E. Involution of the parathyroid glands after renal transplantation. Cur Opinion Neph Hypertension 2003; 12: 363-371.
14. Saunders RN, Karoo R, Metcalfe MS, Nicholson ML. Four gland parathyroidectomywithout reimplantation in patients with chronic renal failure. Postgrad Med J 2005; 81: 255-258.
15. Schlosser K, Zielke A, Rothmund M. Medical and surgical treatment for secondary and tertiary hyperparathyroidism. Scan J Surg 2004; 93: 288-297.
16. Barman Balfour JA, Scott LJ. Cinacalcet hydrochloride. Drugs 2005; 65: 271-281.
17. Serra AL, Schwarz AA, Wick FH, Marti H-P, Wuthrich RP. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Neph Dial Transpl 2005; 20: 1315-1319.
18. Srinivas TR, Schold JD, Womer KL et al. Improvement in hypercalcemia with cinacalcet after kidney transplantation. Clin J Amer Soc Nephrol 2006; 1: 323-326.
19. Kruse AE, Eisenberger U, Frey FJ, Mohaupt MG. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Neph Dial Transpl 2005; 20: 1311-1314.
20. O'Brien CA, Jia D, Plotkin LI et al. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 2004; 145: 1835-1841.
21. Canalis E. Mechanisms of glucocorticoid-induced osteoporosis. Cur Opinion Rheum 2003; 15: 454-457.
22. Epstein S. Post-transplant bone disease. The role of immunosuppressive agents on the skeleton. J Bone Miner Res 1996; 11: 1-7.
23. Ambhul PM, Meier D, Wolf B, Dydak U, Boesiger P, Binswanger U. Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: Impact on muscular phosphate content, mineral metabolism and acid/base homeostasis. Amer J Kid Dis 1999; 34: 875-883.
24. Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y. Natural history of parathyroid function and calcium metabolism after kidney transplantation: A single-centre study. Neph Dial Transpl 2002; 19: 1281-1287.
25. D'Angelo A, Calo L, Giannini S et al. Parathyroid hormone and bone metabolism in kidney-transplanted patients. Clin Neph 2000; 53: 19-22.
26. Oregon LM, Taylor MF, Mir G et al. Parathyroidectomy for parathyroid carcinoma in renal transplantation. Transpl Proceed 2005; 37: 973-976.
27. El-Husseini AA, El-Agroudy AE, El-Sayed M, Sobh MA, Ghoneim MA. A prospective randomized study for the treatment of bone loss with vitamin D during kidney transplantation in children and adolescents. Amer J Transplant 2004; 4: 2052-2057.
28. Withold W, Friedrich W, Degenhardt S. Serum bone alkaline phosphatase is superior to plasma levels of bone matrix proteins for assessment of bone metabolism in patients receiving renal transplants. Clinica Chimica Acta 1997; 261: 105-115.
29. Nichol PF, Starling JR, Mack E, Klovning JJ, Becker BN, Chen H. Long-term follow-up of patients with tertiary hyperparathyroidism treated by resection of a single or double adenoma. Annals Surg 2002; 235: 673-678.